OpenBilldrug price receipt

NADAC week of 2026-10-14

CARDURA XL 4 MG TABLET

FDA nonproprietary name: doxazosin mesylate

For 30 tablets

Pharmacies pay

$209.67 filed

30 × $6.98895 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$201.43 filed

30 × $6.71443 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.96× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Cardura XL” / “Doxazosin Mesylate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$246.12 estimated

$209.67 + $31.45 (15%) + $5.00 fee per fill = $246.12

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

CARDURA XL 4 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as doxazosin mesylate, under the trade name “Cardura XL”.

FDA gives its dosage form as tablet, film coated, extended release and its route as oral.

The labeler, the company named on the label, is Viatris Specialty LLC.

FDA’s Established Pharmacologic Class for it is alpha-Adrenergic Blocker.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 58151-0078-93.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $209.67 for 30 tablets (30 × $6.98895 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Other strengths, forms and brands

4 other products in the NADAC file share the FDA nonproprietary name doxazosin mesylate with CARDURA XL 4 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
CARDURA XL 4 MG TABLET this page
brand · tablet, film coated, extended release
$6.98895 per EA filed
eff. 2026-09-23
$6.71443 per EA filed
Part D 2024 average
DOXAZOSIN MESYLATE 1 MG TAB
generic · tablet
$0.07519 per EA filed
eff. 2026-09-23
$0.20349 per EA filed
Part D 2024 average
DOXAZOSIN MESYLATE 2 MG TAB
generic · tablet
$0.06355 per EA filed
eff. 2026-09-23
$0.20349 per EA filed
Part D 2024 average
DOXAZOSIN MESYLATE 4 MG TAB
generic · tablet
$0.08343 per EA filed
eff. 2026-09-23
$0.20349 per EA filed
Part D 2024 average
DOXAZOSIN MESYLATE 8 MG TAB
generic · tablet
$0.09759 per EA filed
eff. 2026-09-23 to 2026-09-30
$0.20349 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $6.98895 per EA filed.

Of the 24 other products in FDA’s alpha-Adrenergic Blocker class priced per EA, 0 have a higher middle NADAC price and 24 a lower one. The one in the middle is ALFUZOSIN HCL ER 10 MG TABLET, at $0.10513 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $201.43 for 30 tablets, at an average of $6.71443 per EA in 2024 (2024-01-01 to 2024-12-31) for “Cardura XL” and “Doxazosin Mesylate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 2,157 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for CARDURA XL 4 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Cardura XL / Doxazosin Mesylate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.